You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inactivated-adjuvanted SARS-CoV-2 virus vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,

Recruiting
  • COVID-19 Pandemic
  • COVID-19 Vaccines
  • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
  • CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
  • Surabaya, East Java, Indonesia
    Dr. Soetomo General Hospital
Jun 21, 2023

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022

COVID-19 Trial in Shijiazhuang (SARS-CoV-2 Inactivated Vaccine, Placebo)

Completed
  • COVID-19
  • SARS-CoV-2 Inactivated Vaccine
  • Placebo
  • Shijiazhuang, Hebei, China
    Zanhuang county Center for Disease Control and Prevention
Aug 10, 2022

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
  • Saline solution
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Feb 26, 2023

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

Active, not recruiting
  • COVID-19
  • LYB002V14
  • +2 more
  • Chengdu, Sichuan, China
    Affiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023

SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,

Not yet recruiting
  • SARS-CoV-2
  • +2 more
  • one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
  • +3 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Aug 9, 2022

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))

Completed
  • COVID-19
  • Recombinant SARS-CoV-2 Ad5 vectored vaccine
  • Inactive SARS-CoV-2 vaccine (Vero cell)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022

SARS-CoV-2 Trial in Islamabad (LVRNA009, CoronaVac®)

Not yet recruiting
  • SARS-CoV-2
  • LVRNA009
  • CoronaVac®
  • Islamabad, Pakistan
    Clinical Trial Unit, National Institute of Health
Jun 22, 2022

COVID-19 Trial in Herston (UQSC2 Vaccine, NVX-CoV2373 vaccine)

Not yet recruiting
  • COVID-19
  • UQSC2 Vaccine
  • NVX-CoV2373 vaccine
  • Herston, Queensland, Australia
    Q-Pharm Pty Ltd (Nucleus Network Brisbane)
Mar 8, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Infection Trial in Germany, United States (PRIME-2-CoV_Beta)

Recruiting
  • SARS-CoV-2 Infection
  • Florida City, Florida
  • +6 more
Jan 31, 2023

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

Effectiveness of the COVID-19 Inactivated Vaccine

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 vaccine (Vero cell) inactivated
  • Bandung, Indonesia
  • +3 more
Sep 4, 2022

COVID-19 Trial (GBP510 adjuvanted with AS03, Placebo (Normal Saline))

Not yet recruiting
  • COVID-19
  • GBP510 adjuvanted with AS03
  • Placebo (Normal Saline)
  • (no location specified)
Aug 11, 2022

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)

Active, not recruiting
  • COVID-19
  • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
  • ZF2001
  • Wuhan, Hubei, China
    Hubei Provincial Center for Disease Control and Prevention
Jan 12, 2023

COVID-19 Pneumonia, COVID-19 Trial in Abu Dhabi (SARS-CoV-2 Vaccine (Vero Cell), Inactivated)

Recruiting
  • COVID-19 Pneumonia
  • COVID-19
  • SARS-CoV-2 Vaccine (Vero Cell), Inactivated
  • Abu Dhabi, United Arab Emirates
    Sheikh Khalifa Medical City, SEHA
Jul 10, 2022

SARS-CoV-2 Trial in Melbourne (Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59),

Recruiting
  • SARS-CoV-2
  • Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59)
  • +2 more
  • Melbourne, Victoria, Australia
  • +1 more
Apr 25, 2022

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))

Active, not recruiting
  • COVID-19 Vaccine
  • ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
  • Ciudad Autónoma de Buenos Aires, Argentina
    Unidad de Investigación Clínica Farmacocinética FP Clinical Phar
Dec 21, 2022

COVID-19 Trial in Xuzhou (Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule, Two

Completed
  • COVID-19
  • Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule
  • +11 more
  • Xuzhou, Jiangsu, China
    Suining County Center for Disease Control and Prevention
Feb 22, 2022